Skip to main content
. 2021 Apr 15;13(4):2774–2783.

Table 7.

Comparison of adverse reactions (n, %)

Group Control group (n=48) Research group (n=48) χ2 P
Headache 1 (2.08) 1 (2.08) 0.511 0.475
Dyspnea 1 (2.08) 0 (0.00) 0.000 1.000
Convulsions 0 (0.00) 1 (2.08) 0.000 1.000
Other adverse reactions 1 (2.08) 1 (2.08) 0.511 0.475
Total incidence 3 (6.25) 3 (6.25) 0.511 0.475